Citadel Advisors’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Citadel Advisors's ALHC Position: Q2 2026 in Review
Citadel Advisors sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 5,362,666 shares — an estimated $103M sold.
Citadel Advisors first reported a position in ALHC in Q2 2021 and held it in 18 quarters. The position peaked at $117M in Q2 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Citadel Advisors reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
- Citadel Advisors sold 5,362,666 Alignment Healthcare shares in Q2 2026, an estimated $103M.
- Citadel Advisors first reported a position in Alignment Healthcare in Q2 2021 and held it in 18 quarters.
- Citadel Advisors's Alignment Healthcare position peaked at $117M in Q2 2025.
- 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.